Top 5 Pharmaceutical And Medical Devices/Diagnostic Companies In The U.S. By End-use

Report Overview

The U.S. pharmaceutical market size was estimated at USD 574.37 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.48% from 2024 to 2030. Despite the setback due to COVID-19 in certain application areas, the pharmaceutical companies have remained agile. Key players are constantly focusing on developing novel drugs and receiving approval powering market growth.

Moreover, its market is occupied by numerous highly skilled and educated professionals across various occupations, such as technical support, scientific research, and manufacturing. For instance, the U.S. tops the list in recruiting skilled professionals for the pharmaceutical sector. From November 2021 to January 2022, the proportion of big data roles requirement in the pharmaceutical sector increased from 58% to 61.4% in 3 months. The pharmaceutical industry created around 3.2 million indirect jobs and over 800,000 direct jobs.

New primary care models, such as direct primary care and concierge services, are expected to increase physician practice revenue. These practice models provide annual membership to patients for primary care and preventive care, which in turn may reduce overall healthcare costs. Moreover, these practices have also collaborated with Medicare and private insurance providers to make primary care accessible and affordable.

Several initiatives, such as financial relief funds and improving accessibility & availability of primary care physicians, are expected to relieve the U.S. healthcare system from financial and other burdens created by the pandemic. In the U.S., PCPs mostly practice in independent or small healthcare settings; however, in recent years, many physicians are now working with large physician groups or hospitals. As per the Primary Care in the United States 2019 by Robert Graham Center (RGC), around 48% of PCPs are partial or full owners of the practice, and around 48% of these providers work for employed physicians. Out of all primary care providers working in non-physician-owned practices, around 50% are in insurers, HMOs, health plans, or corporate-owned practices, and around 47% are in community health, academic, or medical centers. 

Top 5 Pharmaceutical and Medical Devices/Diagnostic Companies in the U.S. By End Use Report Scope

Market Overview

Sales Revenue:

The sales revenue (USD Million) values are sale estimates of the company targeting various end users including Primary Care Physicians (PCPs), Family Practitioners (FPs), General Practitioners (GPs), Internal Medicine specialists (IMs), Obstetricians/Gynecologists (ObGyns), and Gastroenterologists (GIs). They signify revenue generated from pharmaceutical and medical device companies from these specific end use segments. End users refer to doctors in different setting (PCP and GI) who prescribe or recommend drugs and diagnostic tests to patients.

Sales Force:

The sales force value signifies the total number of sales employees targeting various end users including Primary Care Physicians (PCPs), Family Practitioners (FPs), General Practitioners (GPs), Internal Medicine specialists (IMs), Obstetricians/Gynecologists (ObGyns), and Gastroenterologists (GIs).